The COVID-19 pandemic has upended much of the global economy. While most individual's lives have been disrupted, we are still seeing tremendous progress in the scientific community to research this virus and ultimately create a vaccine.
As a provider of primary cells to researchers around the world, Cell Systems is ready to ship cells, media and reagents to enable valuable research to continue. Though the insights surrounding this virus are still in the early stage, there has been some interesting papers surrounding COVID-19 and vascular biology -- particularly endothelial cells, including this one in The Lancet.
Cell Systems has a large inventory of endothelial cells ready for research. One feature of our cells that is unique is that all of our cells are antibody free. This makes for a more biologically relevant tool and a more effective way to enhance insights.
Another great source of scientific literature surrounding COVID-19 can be found at BizGenius. Updated daily, there are over a thousand papers already published on various subject matters. Thank you BizGenius for putting this highly valuable source on your website.